|
Volumn 25, Issue 6, 2017, Pages 1839-1845
|
Antimicrobial activity of rhodanine-3-acetic acid derivatives
|
Author keywords
2 (4 Oxo 2 thioxothiazolidin 3 yl)acetic acid; Amides; Antibacterial activity; Antifungal activity; Antimycobacterial activity; Condensation; Esters; In vitro activity; Rhodanine
|
Indexed keywords
2 (4 OXO 2 THIOXOTHIAZOLIDIN 3 YL) N PHENYLACETAMIDE DERIVATIVE;
2 (4 OXO 2 THIOXOTHIAZOLIDIN 3 YL)ACETIC ACID;
2 [4 OXO 5 (PYRIDIN 2 YLMETHYLENE) 2 THIOXOTHIAZOLIDIN 3 YL]ACETIC ACID;
2 [5 (2 ACETOXYBENZYLIDENE) 4 OXO 2 THIOXOTHIAZOLIDIN 3 YL]ACETIC ACID;
2 [5 (2 HYDROXYBENZYLIDENE) 4 OXO 2 THIOXOTHIAZOLIDIN 3 YL]ACETIC ACID;
2 [5 (3 HYDROXYBENZYLIDENE) 4 OXO 2 THIOXOTHIAZOLIDIN 3 YL]ACETIC ACID;
2 [5 (4 HYDROXYBENZYLIDENE) 4 OXO 2 THIOXOTHIAZOLIDIN 3 YL]ACETIC ACID;
2 [5 (5 BROMO 2 HYDROXYBENZYLIDENE) 4 OXO 2 THIOXOTHIAZOLIDIN 3 YL] N (4 CHLOROPHENYL)ACETAMIDE;
2 [5 (5 BROMO 2 HYDROXYBENZYLIDENE) 4 OXO 2 THIOXOTHIAZOLIDIN 3 YL]ACETIC ACID;
2 [5 (5 CHLORO 2 HYDROXYBENZYLIDENE) 4 OXO 2 THIOXOTHIAZOLIDIN 3 YL] N (4 CHLOROPHENYL)ACETAMIDE;
2 [5 (5 CHLORO 2 HYDROXYBENZYLIDENE) 4 OXO 2 THIOXOTHIAZOLIDIN 3 YL]ACETIC ACID;
4 (TRIFLUOROMETHYL)PHENYL 2 (4 OXO 2 THIOXOTHIAZOLIDIN 3 YL)ACETATE;
4 NITROPHENYLAMIDE;
ACETIC ACID DERIVATIVE;
ANTIINFECTIVE AGENT;
ANTIMYCOBACTERIAL AGENT;
BACITRACIN;
FLUCONAZOLE;
ISONIAZID;
N (4 CHLOROPHENYL) 2 (4 OXO 2 THIOXOTHIAZOLIDIN 3 YL)ACETAMIDE;
N (4 CHLOROPHENYL) 2 [4 OXO 5 (PYRIDIN 2 YLMETHYLENE) 2 THIOXOTHIAZOLIDIN 3 YL]ACETAMIDE;
N (4 CHLOROPHENYL) 2 [5 (2 HYDROXYBENZYLIDENE) 4 OXO 2 THIOXOTHIAZOLIDIN 3 YL]ACETAMIDE;
N (4 CHLOROPHENYL)AMIDE;
RHODANINE 3 ACETIC DERIVATIVE;
UNCLASSIFIED DRUG;
ACETIC ACID;
RHODANINE;
ANTIBACTERIAL ACTIVITY;
ANTIBIOTIC SENSITIVITY;
ANTIFUNGAL ACTIVITY;
ANTIMICROBIAL ACTIVITY;
ARTICLE;
ATYPICAL MYCOBACTERIUM;
CONTROLLED STUDY;
DRUG SCREENING;
DRUG SYNTHESIS;
FUNGUS;
GRAM NEGATIVE BACTERIUM;
GRAM POSITIVE BACTERIUM;
IN VITRO STUDY;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MINIMUM INHIBITORY CONCENTRATION;
MYCOBACTERIUM;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
STRUCTURE ACTIVITY RELATION;
CANDIDA;
CARBON NUCLEAR MAGNETIC RESONANCE;
CHEMISTRY;
DRUG EFFECTS;
INFRARED SPECTROPHOTOMETRY;
MICROBIAL SENSITIVITY TEST;
PROTON NUCLEAR MAGNETIC RESONANCE;
ACETIC ACID;
ANTI-INFECTIVE AGENTS;
CANDIDA;
CARBON-13 MAGNETIC RESONANCE SPECTROSCOPY;
GRAM-POSITIVE BACTERIA;
METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;
MICROBIAL SENSITIVITY TESTS;
PROTON MAGNETIC RESONANCE SPECTROSCOPY;
RHODANINE;
SPECTROPHOTOMETRY, INFRARED;
|
EID: 85012012607
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2017.01.045 Document Type: Article |
Times cited : (33)
|
References (23)
|